Posted: Mar 24, 2021 in News
People living with lupus will soon have access to a breakthrough treatment discovered by an Albertan life sciences entrepreneur, who is creating a more globally......
Posted: Mar 24, 2021 in News
API is thrilled to announce that Nobel Laureate Dr. Michael Houghton has now joined the institute’s Scientific Advisory Board....
Posted: Mar 23, 2021 in News
The COVID-19 pandemic has further emphasized the need to have manufacturing capacity in Canada not only for vaccines, but to fill drug shortages related to......
Posted: Mar 17, 2021 in News
Applied Pharmaceutical Innovation (API) is pleased to announce a partnership with Campus Alberta Neuroscience (CAN) to continue to expand innovative research and commercialization opportunities in......
Posted: Mar 12, 2021 in News
We're incredibly fortunate to have Allan Aginsky as Vice President of Special Projects and Manufacturing at API. Learn more about his career and his expertise......
Posted: Mar 8, 2021 in News
In our latest video interview, Dr. Launa Aspeslet talks about the strength of the life sciences sector in Alberta, as well as the team collaboration......
Posted: Mar 5, 2021 in News
Alberta-based Applied Pharmaceutical Innovation has partnered with IRICoR, a Quebec-based Centre of Excellence in Commercialization and Research specialized in drug discovery, to expand drug discovery,......
Posted: Mar 3, 2021 in News
Featuring Dr. Rakesh Bhat, Director of Laboratory Science at API and Post-Doctoral Fellow Dr. Archana Koul. Learn more about them and what they're working on......
Posted: Mar 2, 2021 in News
Brilliant researchers like Dr. Michael Houghton (recent Nobel Prize Winner) are part of what makes Alberta a phenomenal destination for life sciences companies....
Posted: Feb 22, 2021 in News
Dr. Robert Foster, CEO of Hepion Pharmaceuticals February 22, 2021 - Edmonton, Alberta A drug discovered in Edmonton has just been approved by the FDA......
Posted: Feb 11, 2021 in News
Applied Pharmaceutical Innovation (API) and Antimicrobial Resistance – One Health Consortium (OHC) have entered a memorandum of understanding to develop the relationship between antimicrobial research......
Posted: Jan 28, 2021 in News
Applied Pharmaceutical Innovation (API) and Bioinformatics Network Alberta (BioNet) have entered a partnership to continue to expand and fuel the growing world-class research landscape present......